Benefit of prostaglandin infusion in severe heart failure: Preliminary clinical experience of repetitive administration

International Journal of Cardiology

Volumn 146, Issue 1, 2011, Pages

  Serra, Walter ^a   Musiari, Luisa ^b   Ardissino, Diego ^a   Gherli, Tiziano ^a   Montanari, Alberto ^b  

^a Parma Hospital   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

End stage heart failure; Prostaglandins, Pulmonary hypertension

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; FUROSEMIDE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN E1;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT OUTCOME;

AGED; ALPROSTADIL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 78049245041     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.12.173     Document Type: Article

References (30)

1. M.D. Freed, M.A. Heymann, A.B. Lewis, S.L. Roehl, and R.C. Kensey Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease Circulation 64 1981 899 905
2. A.G. Olsson, and L.A. Carlson Clinical, hemodynamic and metabolic effects of intraarterial infusions of prostaglandin E1 in patients with peripheral vascular disease Adv Prostaglandin Thromboxane Res 1 1976 429 432
3. S. Murali, R.L. Kormos, and B.F. Uretsky Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience Am Heart J 126 1993 896 904
4. S. Murali, B.F. Uretsky, P.S. Reddy, T.R. Tokarczyk, and A.R. Betschart Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents Am Heart J 122 5 1991 1375 1381
5. J.H. Wilkens, H. Wilkens, and B. Elger Cardiac and microcirculatory effects of different doses of prostaglandin E1 in man Eur J Clin Pharmacol 33 1987 133 137
6. M. Hulsmann, B. Stanek, and B. Frey Hemodynamic and neurohormonal effects of long-term of prostaglandin E1 infusion in outpatients with severe congestive heart failure J Heart Lung Transplant 16 5 1997 556 562
7. M. Packer Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure Circulation 77 6 Pt 2 1988 164 173
8. M. Wutte, M. Hulsmann, and R. Berger Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure Wien Klin Wochenschr 110 13-14 Jul 31 1998 473 478
9. A. Wimmer, B. Stanek, and L. Kubecova Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohormonal variables in patients with advanced heart failure Jpn Heart J 40 3 1999 321 334
10. V. Tilsner Activierung der endogen fibrinolyse durch prostaglandin E1 H. Heidrich, W. Rogatti, Prostaglandin E1 wirkungen und therpeutische wirksamkert 1998 Springer-Verlag Berlin 76 82
11. W. Terres, C. Beythien, W. Kupper, and W. Bleifeld Effect of aspirin and prostaglandin E1 on in vitro thrombolysis with urokinase Circulation 79 1989 1309 1314
12. R. Packer, B. Stanek, and M. Hulsmann Prostaglandin E1-bridge to cardiac transplantation. Technique, dosage, results Eur Heart J 18 1997 318 323
13. R. Packer, P. Meng, and M. Wutte Pharmacological bridging therapy before heart transplantation. First results with continuous PGE1 infusion therapy alone or in combination with catecholamines A.F. Hammerle, MODS: Multi-organ Dysfunction Syndrome 1994 Wien-Munchen Bern Maudrich 70 76
14. B. Stanek, B. Sturm, and B. Frey Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine J Heart Lung Transplant 18 4 1999 358 366
15. W.J. McKenna, K. Swedberg, F. Zanned, M. Gheorghiade, R.M. Califf, and on behalf of the FIRST investigators Experience of chronic intravenous epoprostenol infusion in end-stage cardiac failure: result of FIRST (abstract suppl) Eur Heart J 15 1994 36
16. R. Pacher, B. Stanek, and M. Hulsmann Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohormonal variables J Heart Lung Transplant 16 8 1997 878 881
17. D.M. Kerins, R. Murray, and G.A. FitzGerald Prostacyclin and prostaglandin E1: molecular mechanism and therapeutic utility Prog Hemost Thromb 10 1991 307 337
18. N. Kieler-Jensen, S. Lundin, and S.E. Risksten Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1 and sodium nitroprusside J Heart Lung Transplant 14 1995 436 443
19. R.M. Califf, K.F. Adams, W.J. McKenna, K. Swedberg, F. Zanned, and M. Gheorghiade A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the FLOLAN International Randomized Survival Trial (FIRST) Am Heart J 134 1997 44 54
20. D.J. Sahn, A. De Maria, J. Kisslo, and A. Weyman Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1978 1072 1083
21. M. Pozzoli, S. Capomolla, G. Pinna, F. Cobelli, and L. Tavazzi Doppler echocardiographic evaluation reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation J Am Coll Cardiol 27 1996 883 893 (Pubitemid 26104870)
22. ESC Guidelines on diagnosis and treatment of pulmonary arterial hypertension Eur Heart J 25 2004 2241 2278
23. T. Metsa-Ketela Cyclic AMP-dependent and independent effect of prostaglandins on contraction-relaxation of spontaneously beating isolated rat atria Acta Physiol Scand 112 1981 481 485
24. M.M. Shecther, O. Agranat, Y. Har-Zahav, S. Rath, E. Kaplinsky, and B. Rabinowitz Prostaglandin E1 during angioplasty as preventative therapy for coronary restenosis Am J Ther Nov-Dec 4 1997 395 400
25. T. Kawamura, N. Nara, M. Kadosaki, K. Inada, and S. Endo Prostaglandin E1 reduces myocardial reperfusion injury by inhibition proinflammatory cytokines production during cardiac surgery Crit Care Med 28 7 Jul 2000 2201 2208
26. J. Kermode, W. Butt, and F. Shann Comparison between prostaglandin E1 and epoprostenol (prostacyclin) in infants after heart surgery Br Heart J 66 1991 175 178
27. E. Dagher, L. Dumont, C. Chartrand, and G. Blaise Effects of PGE1 in experimental vasoconstrictive pulmonary hypertension Eur Surg Res 25 1993 65 73
28. B. Stanek Pharmacologic bridging with prostaglandin E1 before heart transplantation. A new chance for an old drug J Clin Basic Cardiol 5 2002 172 177
29. R. Berger, D. Moertl, and M. Huelsmann Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure Eur J Heart Failure 9 2007 202 208
30. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150